Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Cor a 1Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.1 - Asymptomatic2014BelgiumIgE1593.33020140718, Faber MA
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8611.62020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164085.85020100301, Scala E
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7635.50020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2014SpainIgE6721.00020140625, Armentia A
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3517.14020130605, Simon D
1.12 - Oral Allergy Syndrome2014BelgiumIgE3894.74020140718, Faber MA
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9628.13020120528, Patelis A
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9615.63020120528, Patelis A
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14016.43020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2050.00020091005, Ott H
1.5 - Atopic Dermatitis, Diagnosed2014Korea, Republic ofIgE254.00020140821, Choi JS
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE21155.90020140331, Rockmann H
1.6 - Anaphylaxis, Diagnosed2014BelgiumIgE3737.84020140718, Faber MA
1.9 - Pollen Allergy2014Czech RepublicIgE82631.30020140606, Panzner P
1.9 - Pollen Allergy2014SpainIgE506.00020140625, Armentia A
10.1 - Normal Control2014BelgiumIgE150.00020140718, Faber MA
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.2.1 - Source Sensitized (IgE)2014United StatesIgE2979.30020140606, Kattan JD
4.1.1 - Heterologous Source Sensitized (Symptoms)2013NetherlandsIgE8292.68020130415, Masthoff LJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2222.73020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012NetherlandsIgE4280.95020120905, Le TM
4.1.5 - Heterologous Source Sensitized (IgE)2014AustriaIgE35100.00020141020, Guhsl EE
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2065.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2011ItalyIgE108463.65020110211, DAvino R
4.1.6 - Heterologous Source Sensitized (High IgE)2011AustriaIgE6098.33020110211, DAvino R
4.1.6 - Heterologous Source Sensitized (High IgE)2011ItalyIgE21499.53020110211, DAvino R
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2013AustriaIgE2095.00020130401, Berneder M
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3762.16020090826, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE5510.90020120726, Pedrosa M
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE6814.70020120726, Pedrosa M
5.1.1 - Source Exposed (Symptoms)2013NetherlandsIgE7979.75020130415, Masthoff LJ
5.2.1 - Source Exposed (Symptoms, SPT)2004SpainIgE263.800
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9972.73020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2010BelgiumIgE200.00020100628, Verweij MM
5.3.1 - Source Exposed (Symptoms, IgE)2014United StatesIgE1384.60020140606, Kattan JD
6.2 - General Population (Adults)2012SwedenIgE37116.71020120528, Patelis A
6.2 - General Population (Adults)2012SwedenIgE3713.50020120528, Patelis A
5.7.2 - Source Exposed (Provocation Test - Ingestion)2003Denmark / SwitzerlandIgE (IB)1794.100
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004Germany / SwitzerlandIgE (IB)6598.500
Developed by
Panservice